Novo Nordisk · 16 hours ago
Internship - Field Systems (Multiple Positions)
Plainsboro, NJ, US
Internship
Onsite
InternNovo Nordisk is a global pharmaceutical company focused on improving patient outcomes in cardiometabolic diseases. The Field Systems internship offers students hands-on experience in Customer Relationship Management, Field Business Intelligence, and Field Training and Education, while working on strategic projects and collaborating with cross-functional teams.
BiotechnologyHealth CareMedicalPharmaceutical
No H1B
Responsibilities
Working directly with the field on strategic projects
Helping with new field facing systems
Data aggregation and/or field communications
Attend internal meetings
Work on cross functional projects
See through completion at least two-three active projects
Take on more projects depending on uptake and knowledge of the scope of the projects
Qualification
Required
Must be a current student enrolled or recently graduated (graduation date no earlier than April 2026) at/from an accredited college or university pursuing at least a bachelor's degree
Strong academic record with a preferred cumulative GPA of 3.0 or higher
Conscientious self-starter with good organizational skills, project management skills and attention to detail
Ability to balance multiple projects and priorities, must be able to multi-task
Strong interpersonal communication and ability to collaborate with teams; must effectively operate independently, across functional lines, and with internal customers
Demonstrated personal initiative, self-motivation, flexibility, adaptability and willingness to learn
Proficient in Microsoft Office Tools including Word, Excel, PowerPoint, etc
Preferred
A completed or in progress undergraduate or graduate degree in Business Administration, Marketing, Finance or a related discipline preferred
Company
Novo Nordisk
Novo Nordisk is a healthcare company that produces and distributes insulin and other diabetes drugs to treat chronic diseases.
Founded in 1923
10001+ employees
Funding
Current Stage
Public CompanyTotal Funding
$22M2018-12-05Post Ipo Equity· $22M
1981-07-09IPO
Leadership Team
Lars Fruergaard Jørgensen
President and CEO
Lars Sorensen
President & CEO
Recent News
Labiotech UG
2026-01-24
bloomberglaw.com
2026-01-24
Company data provided by crunchbase